RecruitingNCT06981156

Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)


Sponsor

University of Wisconsin, Madison

Enrollment

75 participants

Start Date

May 13, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to investigate a neurologic exam scale to provide an objective and more standard way to assess tumor response in pediatric patients with brain and spinal cord tumors.


Eligibility

Min Age: 1 YearMax Age: 17 Years

Inclusion Criteria4

  • greater than or equal to 1 year old
  • must be seen in the pediatric clinic
  • Radiographic or histologic confirmation of a brain or spine tumor at the time of initial diagnosis
  • Patient or parent/guardian must be able to understand the consent and be willing to sign a written informed consent document according to institutional guidelines.

Exclusion Criteria1

  • none specified

Interventions

DIAGNOSTIC_TESTpNANO Assessment

pNANO assesses patient gait, strength, cerebellar function, visual fields, visual acuity, facial strength, level of consciousness, extraocular movement, dysarthria, and dysphagia The patient will be assessed by 2-3 different clinicians during each of 2 visits.


Locations(1)

American Family Children's Hospital

Madison, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06981156


Related Trials